Question 1

Does JPMorgan Chase own ARKG stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 7,443,296 shares of ARKG (Ark Genomic Revolution ETF), worth $315.3M.

Question 2

How many shares of ARKG does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 7,443,296 shares of ARKG (Ark Genomic Revolution ETF).

Question 3

What is JPMorgan Chase's ARKG position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's ARKG position is worth $315.3M.

Question 4

Is JPMorgan Chase buying or selling ARKG?

Accepted Answer

In Q2 2026, JPMorgan Chase increased its ARKG position by 212,487 shares (+2.9%).

Question 5

When did JPMorgan Chase first buy ARKG?

Accepted Answer

JPMorgan Chase already held ARKG in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	7.4M	+2.9%	$315.3M	0.0%	$42.06	32
2026-Q1	Increased	7.2M	+40.4%	$179.5M	0.0%	$26.42	40
2025-Q4	Increased	5.1M	+30.6%	$149.2M	0.0%	$28.97	38
2025-Q3	Decreased	3.9M	-9.4%	$109.5M	0.0%	$27.77	0
2025-Q2	Increased	4.4M	+26.8%	$106M	0.0%	$24.35	37
2025-Q1	Increased	3.4M	+23.0%	$71.3M	0.0%	$20.76	36
2024-Q4	Decreased	2.8M	-5.5%	$65.7M	0.0%	$23.55	0
2024-Q3	First report	3M	-	$75.7M	0.0%	$25.60	0